Changes in M‐protein response
Changes from the baseline to the best M‐protein response (%) in this study were as follows: M‐protein response decreased by ≥ 90% and ≥ 50% in 36.1% and 75.0% in all the patients; M‐protein response decreased by ≥90%, 50%–90%, and ≥ 50% in 47.4%, 31.6% and 78.9% patients in the ICd group, respectively, and in 23.5%, 47.1%, and 70.6% patients in the Id group, respectively (Figure Changes of M‐protein from basline to best response during the treatment of ICd or Id regimen. M‐protein: monoclonal immunoglobulin.